BioPharm International
BioPharm International-08-01-2009
Volume: 22
Issue: 8
BioPharm International-07-01-2009
Volume: 22
Issue: 7
BioPharm International-06-01-2009
Volume: 22
Issue: 6
BioPharm International-06-02-2009
Volume: 2009 Supplement
Issue: 4
BioPharm International-05-01-2009
Volume: 22
Issue: 5
BioPharm International-04-01-2009
Volume: 22
Issue: 4
BioPharm International-04-02-2009
Volume: 2009 Supplement
Issue: 3
BioPharm International-03-01-2009
Volume: 22
Issue: 3
BioPharm International-03-02-2009
Volume: 2009 Supplement
Issue: 2
BioPharm International-02-01-2009
Volume: 22
Issue: 2
BioPharm International-01-02-2009
Volume: 2009 Supplement
Issue: 1
BioPharm International-01-01-2009
Volume: 22
Issue: 1
BioPharm International-12-01-2008
Volume: 21
Issue: 12
BioPharm International-11-02-2008
Volume: 2008 Supplement
Issue: 7
BioPharm International-11-01-2008
Volume: 21
Issue: 11
BioPharm International-10-02-2008
Volume: 2008 Supplement
Issue: 6
BioPharm International-10-01-2008
Volume: 21
Issue: 10
BioPharm International-09-01-2008
Volume: 21
Issue: 9
BioPharm International-08-01-2008
Volume: 21
Issue: 8
BioPharm International-07-01-2008
Volume: 21
Issue: 7
BioPharm International-06-01-2008
Volume: 21
Issue: 6
BioPharm International-06-02-2008
Volume: 2008 Supplement
Issue: 5
BioPharm International-05-01-2008
Volume: 21
Issue: 5
BioPharm International-04-02-2008
Volume: 2008 Supplement
Issue: 4
BioPharm International-04-01-2008
Volume: 21
Issue: 4
BioPharm International-03-01-2008
Volume: 21
Issue: 3
BioPharm International-03-02-2008
Volume: 2008 Supplement
Issue: 3
BioPharm International-02-01-2008
Volume: 21
Issue: 2
BioPharm International-02-02-2008
Volume: 2008 Supplement
Issue: 2
BioPharm International-01-02-2008
Volume: 2008 Supplement
Issue: 1
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5